LexaGene Holdings (CVE:LXG) President Daryl Rebeck tells Proactive Investors about how the biotech company continues to develop and commercialize pathogen detection devices in the biochemical industry.
Rebeck says pathogens are anything that can make us ill, such as salmonella, E. coli, respiratory diseases, Lyme disease. The instrument LexaGene offers quickly detects multiple pathogens with sensitivity and specificity.
"It's a very easy-to-use instrument," says Rebeck.
The platform could be used in food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and other markets.